Shandong Xinhua Pharmaceutical Company Limited (XIN) — Cash Flow-to-Debt Ratio
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2023, meaning its operating cash flow of €56.11 Million could theoretically repay 0% of its total liabilities (€3.22 Billion) in one year. Explore how much of Shandong Xinhua Pharmaceutical Company L's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Xinhua Pharmaceutical Company Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. Also explore XIN total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year debt coverage analysis for Shandong Xinhua Pharmaceutical Company Limited. For market capitalisation and broader financial context, see Shandong Xinhua Pharmaceutical Company L market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | €533.73 Million | €3.73 Billion | ▲ +48.0% |
| 2024 | 0.10x | €367.61 Million | €3.80 Billion | ▲ +27.9% |
| 2023 | 0.08x | €265.28 Million | €3.51 Billion | ▼ -61.0% |
| 2022 | 0.19x | €758.24 Million | €3.92 Billion | ▲ +175.1% |
| 2021 | 0.07x | €259.12 Million | €3.68 Billion | ▼ -38.0% |
| 2020 | 0.11x | €420.19 Million | €3.70 Billion | ▲ +8.4% |
| 2019 | 0.10x | €348.27 Million | €3.33 Billion | ▲ +0.9% |
| 2018 | 0.10x | €323.91 Million | €3.12 Billion | ▼ -28.3% |
| 2017 | 0.14x | €389.97 Million | €2.69 Billion | ▼ -12.9% |
| 2016 | 0.17x | €439.35 Million | €2.64 Billion | ▲ +19.6% |
| 2015 | 0.14x | €348.64 Million | €2.51 Billion | ▼ -6.4% |
| 2014 | 0.15x | €346.34 Million | €2.33 Billion | ▲ +200.6% |
| 2013 | 0.05x | €104.99 Million | €2.13 Billion | — |